Insufficient scRNA-seq data for expression of ADPRH at single-cell level.
Insufficient scRNA-seq data for expression of ADPRH at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 1002.72 | 653 / 653 | 100% | 10.53 | 605 / 605 |
breast | 100% | 1273.18 | 459 / 459 | 99% | 10.34 | 1106 / 1118 |
prostate | 100% | 862.82 | 244 / 245 | 99% | 12.20 | 496 / 502 |
pancreas | 98% | 611.43 | 322 / 328 | 99% | 9.51 | 177 / 178 |
kidney | 100% | 597.29 | 89 / 89 | 98% | 13.61 | 879 / 901 |
lung | 100% | 1556.59 | 578 / 578 | 97% | 9.67 | 1121 / 1155 |
uterus | 100% | 832.34 | 170 / 170 | 91% | 6.80 | 418 / 459 |
stomach | 98% | 517.19 | 352 / 359 | 93% | 5.97 | 266 / 286 |
bladder | 100% | 874.43 | 21 / 21 | 90% | 6.95 | 454 / 504 |
adrenal gland | 100% | 956.17 | 257 / 258 | 90% | 6.86 | 208 / 230 |
intestine | 99% | 781.96 | 961 / 966 | 90% | 5.51 | 473 / 527 |
esophagus | 97% | 743.84 | 1398 / 1445 | 92% | 5.83 | 168 / 183 |
skin | 85% | 310.33 | 1538 / 1809 | 97% | 16.70 | 457 / 472 |
ovary | 69% | 249.92 | 124 / 180 | 96% | 5.60 | 411 / 430 |
brain | 49% | 135.76 | 1285 / 2642 | 89% | 6.24 | 628 / 705 |
liver | 45% | 135.60 | 102 / 226 | 71% | 3.63 | 287 / 406 |
adipose | 100% | 1493.38 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1069.25 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 37.56 | 29 / 29 |
muscle | 100% | 1061.84 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1610.13 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.82 | 1 / 1 |
heart | 99% | 728.27 | 855 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 7.29 | 77 / 80 |
tonsil | 0% | 0 | 0 / 0 | 96% | 6.93 | 43 / 45 |
peripheral blood | 87% | 1269.99 | 809 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051725 | Biological process | protein de-ADP-ribosylation |
GO_0036211 | Biological process | protein modification process |
GO_0005615 | Cellular component | extracellular space |
GO_0030955 | Molecular function | potassium ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0003875 | Molecular function | ADP-ribosylarginine hydrolase activity |
Gene name | ADPRH |
Protein name | ADP-ribosylarginine hydrolase ADP-ribosylhydrolase ARH1 (EC 3.2.2.19) (ADP-ribose-L-arginine cleaving enzyme) ([Protein ADP-ribosylarginine] hydrolase) (ADP-ribosylarginine hydrolase) (hARH1) |
Synonyms | ARH1 |
Description | FUNCTION: Specifically acts as an arginine mono-ADP-ribosylhydrolase by mediating the removal of mono-ADP-ribose attached to arginine residues on proteins. . |
Accessions | C9JZW7 ENST00000481816.5 ENST00000478399.5 ENST00000465513.1 ENST00000357003.8 P54922 ENST00000478927.5 |